These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23519403)

  • 1. Effect of low concentrations of benzalkonium chloride on acanthamoebal survival and its potential impact on empirical therapy of infectious keratitis.
    Tu EY; Shoff ME; Gao W; Joslin CE
    JAMA Ophthalmol; 2013 May; 131(5):595-600. PubMed ID: 23519403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
    Hesje CK; Borsos SD; Blondeau JM
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
    Blondeau JM; Borsos S; Hesje CK
    J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.
    Haas W; Pillar CM; Hesje CK; Sanfilippo CM; Morris TW
    J Antimicrob Chemother; 2011 Apr; 66(4):840-4. PubMed ID: 21393192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy.
    Kowalski RP; Kowalski BR; Romanowski EG; Mah FS; Thompson PP; Gordon YJ
    Am J Ophthalmol; 2006 Nov; 142(5):730-5. PubMed ID: 16978577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
    Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
    Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of isavuconazole against three species of Acanthamoeba.
    Brunet K; Eestermans R; Rodier MH; Cateau E
    J Fr Ophtalmol; 2020 Apr; 43(4):330-333. PubMed ID: 32151474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of standardized methods for assessing biocidal efficacy of contact lens care solutions against Acanthamoeba trophozoites and cysts.
    Kilvington S; Lam A
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4527-37. PubMed ID: 23745008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
    Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
    Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis.
    Romanowski EG; Mah FS; Kowalski RP; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Aug; 24(4):380-4. PubMed ID: 18665809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba.
    Padzik M; Hendiger EB; Chomicz L; Grodzik M; Szmidt M; Grobelny J; Lorenzo-Morales J
    Parasitol Res; 2018 Nov; 117(11):3519-3525. PubMed ID: 30112674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.